Analysis of TSC1 truncations defines regions involved in TSC1 stability, aggregation and interaction
Authors:
- Mark NellistMNMark Nellist
- 1 September 2010
- journal article
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
- Vol. 1802 (9) , 774-781
Abstract
No abstract availableKeywords
Funding Information
- U.S. Department of Defense Congressionally-Directed Medical Research Program (#TS060052)
This publication has 21 references indexed in Scilit:
- Defining the Role of mTOR in CancerCancer Cell, 2007
- Activity of TSC2 is inhibited by AKT-mediated phosphorylation and membrane partitioningJournal of Cell Biology, 2006
- Tuberous Sclerosis Complex Gene Products, Tuberin and Hamartin, Control mTOR Signaling by Acting as a GTPase-Activating Protein Complex toward RhebCurrent Biology, 2003
- Rheb Binds Tuberous Sclerosis Complex 2 (TSC2) and Promotes S6 Kinase Activation in a Rapamycin- and Farnesylation-dependent MannerJournal of Biological Chemistry, 2003
- Rheb GTPase is a direct target of TSC2 GAP activity and regulates mTOR signalingGenes & Development, 2003
- Insulin Activation of Rheb, a Mediator of mTOR/S6K/4E-BP Signaling, Is Inhibited by TSC1 and 2Molecular Cell, 2003
- Rheb is a direct target of the tuberous sclerosis tumour suppressor proteinsNature Cell Biology, 2003
- Interaction between hamartin and tuberin, the TSC1 and TSC2 gene productsHuman Molecular Genetics, 1998
- Identification of the Tuberous Sclerosis Gene TSC1 on Chromosome 9q34Science, 1997
- Identification and characterization of the tuberous sclerosis gene on chromosome 16Cell, 1993